Asthma Trial 1
Clinical research study trial for adolescents aged 12 to 17 years with inadequately controlled asthma. It compares a once-daily single-inhaler triple therapy (fluticasone furoate/umeclidinium bromide/vilanterol) with a once-daily single-inhaler double therapy (fluticasone furoate/vilanterol). The study aims to evaluate lung function improvements and safety over a 24-week treatment period.
Asthma Trial 2
This study is enrolling children, teens, and adults who have asthma. This clinical trial is evaluating an investigational drug for people who have had at least one asthma attack in the past year. Participants will be involved in the study for at least six months.
COPD Trial 1
This trial is for adults aged 40-80 with COPD who are current or former smokers. It aims to evaluate whether COPD treatments can help prevent severe heart events like heart attacks and heart failure.
COPD Trial 2
The COPD clinical trial aims to evaluate new treatments by assessing their effectiveness, safety, and impact on patients' quality of life. The goal is to improve COPD management and advance future treatment options.
Migraine
This migraine clinical trial is for children and teenagers aged 6-17 who have been diagnosed with migraines for at least six months, experience migraines on six or more days per month, and have attacks lasting 4 to 72 hours when untreated. The study aims to evaluate a potential preventive treatment over an initial six-month period, with an option for extended participation.
Eczema
We are always looking for candidates for eczema clinical trials. Our studies aim to evaluate new treatments for eczema, focusing on effectiveness, safety, and improving quality of life. If you have eczema and are interested in participating, contact us to see if you qualify.
Hives
This trial is for adults (18+) diagnosed with chronic spontaneous urticaria (CSU) for at least six months. Participants must have symptoms that are not adequately controlled with antihistamines. The trial aims to evaluate the investigational medication’s effectiveness in reducing CSU symptoms, its safety, and its long-term impact on quality of life.
COVID-19
We are always seeking candidates for COVID-19 clinical trials. If you have recently been diagnosed with COVID-19, you may qualify for studies evaluating new treatments and preventive measures. Our research focuses on effectiveness, safety, and long-term health outcomes. Contact us to learn more.